Cas No.: | 1605328-04-8 |
Chemical Name: | N-[4-(4-{[(1S)-1-(5-Methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-1H-indol-6-yl]sulfamide |
Synonyms: | LAS-195319;LAS 195319 |
SMILES: | S(NC1=CC2=C(C(C3C4=C(N[C@@H](C5N(C6=CC=CC=C6)C(=O)C6=C(C)C=CN6N=5)C)N=CN=C4NC=3)=C1)C=CN2)(N)(=O)=O |
Formula: | C29H26N10O3S |
M.Wt: | 594.654 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | LAS195319 (LAS-195319) is a potent, selective, inhaled PI3Kδ inhibitor with IC50 of 0.5 nM, weakly inhibits PI3Kβ and γ (>20-fold), no activity against PI3Kα; inhibits M-CSF induced pAkt (Thr308) in THP-1 cells with IC50 of 2.7 nM; inhibits inflammatory cell infiltration induced by OVA challenge in a Brown Norway rat model. |